Cao, T M <br/><br/>
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  2001 
 - 294-301 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1083-8791 
<br/><br/><label>Standard No.: </label>10.1053/bbmt.2001.v7.pm11400952  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carmustine--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Etoposide--administration & dosage<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Lymphoma, Follicular--classification<br/>Male<br/>Middle Aged<br/>Neural Tube Defects--etiology<br/>Prognosis<br/>Recurrence<br/>Remission Induction<br/>Retrospective Studies<br/>Survival Analysis<br/>Transplantation, Autologous<br/>Treatment Outcome<br/>Whole-Body Irradiation